STAT

A call to scientists idled by shuttered labs: Share your bench skills and resources to fight Covid-19

"This is definitely disrupting a lot of very important projects around the country, but we're scientists. We're adaptable. We're trying to find ways to work around it that’ll be productive."

His lab shut down last week by coronavirus precautions like many others across the U.S., Michael Wells, a postdoctoral fellow at the Broad Institute, was walking home and wondering how he could still help. A neuroscientist who worked on Zika testing, he created a database with like-minded scientists to connect their skills and resources with people who might need them.

In the five days since he put out his call, 6,000 scientists have volunteered and groups from across the country are signaling interest, from a plea for testing swabs to questions about chemicals needed to process the tests.

Wells told STAT more about his project in a recent conversation, which has been condensed and lightly edited.

What’s your background, and what skills

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks